Evidence map›Paper›PMID 28531265›Full record

ReviewILAR journal2017

Utility of Nonhuman Primates in Substance Use Disorders Research.

Matthew L Banks, Paul W Czoty, Sidney S Negus

Open access · bronzeAbstract readReview
In one paragraph

Review in ILAR journal, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
1.7field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 32 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Longevity and Catheter-Related Infection Rates in Nonhuman Primates with Chronic Indwelling Intravenous Catheters.Journal of the American Association for Laboratory Animal Science : JAALAS · 2025
    Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. The lasting impact of methocinnamox on opioid self-administration.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2020
    Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 2 countries.

Matthew L BanksDepartment of Pharmacology and Toxicology, School of Medicine, Virginia Commonwealth University, Richmond, Virginia.
Paul W CzotyDepartment of Physiology and Pharmacology, Wake Forest School of Medicine, Winston-Salem, North Carolina.
Sidney S NegusDepartment of Pharmacology and Toxicology, School of Medicine, Virginia Commonwealth University, Richmond, Virginia.
Institut national de recherche en sciences et technologies du numérique · FR

Funding

Medications Development for Stimulant AbuseR01DA026946 · NIDA · VIRGINIA COMMONWEALTH UNIVERSITY · PI NEGUS, SIDNEY S · 2009 to 2019
$3.7M
Medications Development for Cocaine: A Translational Approach in Monkey and HumanR01DA033364 · NIDA · UNIVERSITY OF KENTUCKY · PI LILE, JOSHUA ANTHONY · 2013 to 2016
$1.9M
Interactions of Ethanol & Cocaine Self-Administration in MonkeysR01DA039953 · NIDA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI CZOTY, PAUL W. · 2016 to 2020
$1.8M
Treatment Development for Methamphetamine AbuseR01DA031718 · NIDA · VIRGINIA COMMONWEALTH UNIVERSITY · PI BANKS, MATTHEW L · 2012 to 2014
$1.1M
Shortening the SOAPP-R: Computer-based opioid risk assessmentR03DA036683 · NIDA · TUFTS UNIVERSITY BOSTON · PI FINKELMAN, MATTHEW · 2014 to 2015
$159k
NIDA NIH HHS R01 DA026946NIDA NIH HHS R01 DA031718NIDA NIH HHS R01 DA033364NIDA NIH HHS R01 DA039953NIDA NIH HHS R03 DA036683
6 · The paper itself

Abstract

Substance use disorders (i.e., drug addiction) constitute a global and insidious public health issue. Preclinical biomedical research has been invaluable in elucidating the environmental, biological, and pharmacological determinants of drug abuse and in the process of developing innovative pharmacological and behavioral treatment strategies. For more than 70 years, nonhuman primates have been utilized as research subjects in biomedical research related to drug addiction. There are already several excellent published reviews highlighting species differences in both pharmacodynamics and pharmacokinetics between rodents and nonhuman primates in preclinical substance abuse research. Therefore, the aim of this review is to highlight three advantages of nonhuman primates as preclinical substance abuse research subjects. First, nonhuman primates offer technical advantages in experimental design compared to other laboratory animals that afford unique opportunities to promote preclinical-to-clinical translational research. Second, these technical advantages, coupled with the relatively long lifespan of nonhuman primates, allows for pairing longitudinal drug self-administration studies and noninvasive imaging technologies to elucidate the biological consequences of chronic drug exposure. Lastly, nonhuman primates offer advantages in the patterns of intravenous drug self-administration that have potential theoretical implications for both the neurobiological mechanisms of substance use disorder etiology and in the drug development process of pharmacotherapies for substance use disorders. We conclude with potential future research directions in which nonhuman primates would provide unique and valuable insights into the abuse of and addiction to novel psychoactive substances.

Indexed as

AnimalsBrainDisease Models, AnimalHumansMacaca mulattaPrimatesSaimiriSubstance-Related DisordersTranslational Research, Biomedicaladdictionanimal modelsbaboonnonhuman primaterhesus monkeysquirrel monkeysubstance abusetranslational

Identifiers

PMID28531265
PMCPMC5886327
OpenAlexW2616784797

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.